IL6 and metabolic dysfunction-associated steatotic liver disease: Taken together, there are discrepancies among studies in terms of the effects of IL-6 on obesity and NAFLD, and further research is required to clarify the effects of IL-6 on NAFLD as a myokine and as an inflammatory cytokine.